Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical Botox during BipolEP for BPH and OAB
NCT05910983Not yet recruiting
- Sponsor
- Menoufia University
- Start
- Jan 2025
- Primary completion
- Nov 2025
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Randomised trial of botulinum toxin type A in overactive bladder (OAB) (2 arms), sponsored by Menoufia University. Primary endpoints: International Prostate Symptom Score at 6 months, Overactive Bladder Symptom Score at 6 months and 2 more. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT05910983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05910983.